Cite
HARVARD Citation
Li, H. et al. (2005). Endostatin Polymorphism 4349G/A(D104N) is not Associated with Aggressiveness of Disease in Postate Cancer. Disease markers. 21 (1), pp. 37-41. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, H. et al. (2005). Endostatin Polymorphism 4349G/A(D104N) is not Associated with Aggressiveness of Disease in Postate Cancer. Disease markers. 21 (1), pp. 37-41. [Online].